Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,813

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,813 results for “outcome study”

Learn how ShareScore rates datasets ↗
dryad28/100

Comparison of outcomes of neurosurgical operations performed before and during the COVID-19 pandemic: a matched cohort study

Open the record for dataset details and reuse information.

publicFeb 2021View details →
dryad28/100

Data from: The influence of the fetal leg position on the outcome in vaginally intended deliveries out of breech presentation at term – a FRABAT prospective cohort study

Open the record for dataset details and reuse information.

publicNov 2019View details →
geo24/100

Study of the DNA methylation in the stroke outcome: an Epigenome-Wide Association Study

GEO Series GSE203399. Homo sapiens. 121 samples. Type: Methylation profiling by array.

openGEO-OpenMay 2022View details →
geo24/100

DNA Methylation Profiling of Glioblastoma: Impact on Gene Expression and Clinical Outcome (Agilent Expression Study)

GEO Series GSE22866. Homo sapiens. 46 samples. Type: Expression profiling by array.

openGEO-OpenJan 2011View details →
geo24/100

Role of epigenetics in the clinical evolution of COVID-19 disease. Epigenome-wide association study identifies markers of severe outcome.

GEO Series GSE199591. Homo sapiens. 187 samples. Type: Methylation profiling by genome tiling array.

openGEO-OpenFeb 2023View details →
geo24/100

Gene expression signatures predict outcome in non-muscle invasive bladder carcinoma - a multi-center validation study

GEO Series GSE5479. Homo sapiens. 808 samples. Type: Expression profiling by array.

openGEO-OpenJun 2007View details →
geo24/100

In Silico ascription of gene expression differences to tumor and stromal cells in a model to study impact on breast cancer outcome

GEO Series GSE24117. Homo sapiens. 213 samples. Type: Expression profiling by array.

openGEO-OpenSep 2010View details →
geo24/100

Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson’s disease: A randomized double-blind prospective study [RNA-Seq]

GEO Series GSE296011. Mus musculus. 24 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenNov 2025View details →
dryad24/100

Data from: Management and outcome of primary CNS lymphoma patients in the modern era. a LOC network study

Objective: Studies on primary CNS lymphoma (PCNSL) patients in the "real life" are scarce. Our objective was to analyze, in a nationwide population-based study, the current medical practice in the management of PCNSL. Methods: The LOC database prospectively records all newly diagnosed PCNSL from 32 French centers. Data of patients diagnosed between 2011-2016 were retrospectively analyzed. Results: We identified 1002 immunocompetent patients (43% aged>70 years, median KPS 60). First-line treatment was high-dose methotrexate-based chemotherapy in 92% of cases, with an increasing use of rituximab over time (66%). Patients <60 years old received consolidation treatment in 77% of cases, consisting of whole-brain radiotherapy (WBRT) (54%) or high-dose chemotherapy with autologous stem cell transplantation (HCT-ASCT) (23%). Among the patients > 60 years old, WBRT and HCT-ASCT consolidation were administered in only 9% and 2%, respectively. The complete response rate to initial chemotherapy was 50%. Median progression-free survival was 10.5 months. For relapse, second-line chemotherapy, HCT-ASCT, WBRT and palliative care were offered to 55%, 17%, 10%, and 18% of patients, respectively. The median, 2-year and 5-year overall survival was 25.3 months, 51% and 38%, respectively (< 60 years: not reached (NR), 70% and 61%; > 60 years: 15.4 months, 44% and 28%). Age, KPS, sex and response to induction CT were independent prognostic factors in multivariate analysis. Conclusions: Our study confirms the increasing proportion of elderly within PCNSL and shows comparable outcome in this population-based study with those reported by clinical trials, reflecting a notable application of recent PCNSL advances in the real life.

opencc-zeroSep 2020View details →
dryad24/100

Data from: Outcomes in patients with infections and augmented renal clearance: a multicenter retrospective study

Recently, augmented renal clearance (ARC), which accelerates glomerular filtration of renally eliminated drugs thereby reducing the systemic exposure to these drugs, has started to receive attention. However, the clinical features associated with ARC are still not well understood, especially in the Japanese population. This study aimed to evaluate the clinical characteristics and outcomes of ARC patients with infections in Japanese intensive care unit (ICU) settings. We conducted a retrospective observational study from April 2013 to May 2017 at two tertiary level ICUs in Japan, which included 280 patients with infections (median age 74 years; interquartile range, 64–83 years). We evaluated the estimated glomerular filtration rate (eGFR) at ICU admission using the Japanese equation, and ARC was defined as eGFR >130 mL/min/1.73 m2. Multivariable logistic regression analysis was performed to identify the independent risk factors for ARC and to determine if it was a predictor of ICU mortality. In addition, a receiver operating curve (ROC) analysis was performed, and the area under the ROC (AUROC) was determined to examine the significant variables that predict ARC. In total, 19 patients (6.8%) manifested ARC. Multivariable logistic regression analysis identified younger age as an independent risk factor for ARC (odds ratio [OR], 0.94; 95% confidence interval [CI], 0.91–0.96). However, ARC was not found to be a predictor of ICU mortality (OR, 0.57; 95% CI, 0.11–2.92). In addition, the AUROC of age was 0.79 (95% CI, 0.68–0.91), and the optimal cut off age for ARC was ≤63 years (sensitivity, 68.4%; specificity, 78.9%). The incidence of ARC was, therefore, low among patients with infections in the Japanese ICUs. Although younger age was associated with the incidence of ARC, it was not an independent predictor of ICU mortality.

opencc-zeroDec 2017View details →
zenodo24/100

Figure 1 from: Dasari S (2016) Studying the effect of Ruthenium on High Temperature Mechanical Properties of Nickel Based Superalloys and Determining the Universal Behavior of Ruthenium at Atomic Scale with respect to alloying elements, Stress and Temperature. Research Ideas and Outcomes 2: e10714. https://doi.org/10.3897/rio.2.e10714

Figure 1 - Chemical composition of TMS 138 alloy.

opencc-by-4.0Oct 2016View details →
zenodo24/100

The impact of obesity on orthodontic treatment outcome in adolescents: a prospective clinical cohort study

<p>Dataset for all analyses of the paper</p>

opencc-by-4.0Nov 2019View details →
dryad24/100

Clinical outcomes in multifocal motor neuropathy: a combined cross-sectional and follow-up study

Objective <p>To assess the clinical course of multifocal motor neuropathy (MMN) in a large cohort of patients and to identify predictive factors of a progressive disease course.</p> Methods <p>Between May 2015 and February 2016, we collected clinical data from 100 patients with MMN of whom 60 had participated in a nationwide cross-sectional cohort study in 2007. We documented clinical characteristics using standardized questionnaires and performed a standardized neurological examination. We used multiple linear regression analysis to identify factors that correlated with worse outcome.</p> Results <p>We found that age of diagnosis (45.2 <i>vs.</i> 48.6 years, <i>p</i>&lt;0.02) significantly increased between 2007 and 2015-2016, whereas diagnostic delay decreased with 15 months. Seven out of ten outcome measures deteriorated over time (all <i>p</i>&lt;0.01). Patients who had a lower MRC sum score and absence of one or more reflexes at the baseline visit showed a greater functional loss at follow up (<i>p</i>=0.007 and <i>p</i>=0.016).</p> Conclusions <p>Our study shows that MMN is a progressive disease. Although 87% of patients received maintenance treatment, muscle strength, reflexes, vibration sense, and the Self-Evaluation Scale significantly deteriorated over time. Lower MRC sum score and absence of reflexes predicted a more progressive disease course.</p> Classification of evidence <p>This study provides Class II evidence that lower MRC sum score and the absence of reflexes predict a more progressive disease course in patients with MMN.</p>

opencc-zeroOct 2021View details →
zenodo24/100

Figure 1 from: Klein A (2016) Crowdsourcing voice editing and quality assessment of data collected from the largest mobile phone-based research study of Parkinson disease. Research Ideas and Outcomes 2: e8848. https://doi.org/10.3897/rio.2.e8848

Figure 1 - Amazon's Mechanical Turk Web site.

opencc-by-4.0Apr 2016View details →
zenodo24/100

Figure 8 from: Klein A (2016) Crowdsourcing voice editing and quality assessment of data collected from the largest mobile phone-based research study of Parkinson disease. Research Ideas and Outcomes 2: e8848. https://doi.org/10.3897/rio.2.e8848

Figure 8 - Example artifacts in mPower voice recordings.

opencc-by-4.0Apr 2016View details →
ClinicalTrials.gov24/100

A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe

ClinicalTrials.gov study NCT05123950. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Clinical Outcomes of Hemodialysis in Brazil (COHEBRA): a Prospective Cohort Study

ClinicalTrials.gov study NCT05273424. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

ClinicalTrials.gov study NCT06008756. IPD Sharing: YES. Countries: 29. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov24/100

Prospective Study to Evaluate Patient Reported Outcomes (PRO) During Rechallenge With Trabectedin in Sarcoma Patients

ClinicalTrials.gov study NCT06050434. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Pilot Study on Molecular Quantitation and Sequencing of Endometrial Cytokines Gene Expression and Their Effect on the Outcome of In-vitro Fertilization (IVF) Cycle

ClinicalTrials.gov study NCT01809509. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record